Novoseven
List of products in the National Drug Code with proprietary name novoseven. This medication is used to treat and prevent bleeding in people with certain conditions (such as hemophilia type A or B, low levels of factor VII, Glanzmann's thrombasthenia). People with these conditions are at risk for bleeding longer after an injury/surgery and for bleeding inside the body (especially into the joints and muscles). This product contains a man-made form of factor VIIa, which is a protein (clotting factor) in the blood that works with other clotting factors to help the blood clot and therefore stop bleeding.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
0169-7010 | Novoseven RT | Coagulation Factor Viia (recombinant) | Kit | Novo Nordisk | Plasma Derivative | |
0169-7020 | Novoseven RT | Coagulation Factor Viia (recombinant) | Kit | Novo Nordisk | Plasma Derivative | |
0169-7040 | Novoseven RT | Coagulation Factor Viia (recombinant) | Kit | Novo Nordisk | Plasma Derivative | |
0169-7050 | Novoseven RT | Coagulation Factor Viia (recombinant) | Kit | Novo Nordisk | Plasma Derivative | |
0169-7201 | Novoseven RT | Coagulation Factor Viia (recombinant) | Kit | Novo Nordisk | Plasma Derivative | |
0169-7202 | Novoseven RT | Coagulation Factor Viia (recombinant) | Kit | Novo Nordisk | Plasma Derivative | |
0169-7205 | Novoseven RT | Coagulation Factor Viia (recombinant) | Kit | Novo Nordisk | Plasma Derivative | |
0169-7208 | Novoseven RT | Coagulation Factor Viia (recombinant) | Kit | Novo Nordisk | Plasma Derivative |